Publication:
Pharmaceutical Reform : A Guide to Improving Performance and Equity

Simple item page
dc.contributor.authorRoberts, Marc J.
dc.contributor.authorReich, Michael R.
dc.date.accessioned2012-03-19T09:04:40Z
dc.date.available2012-03-19T09:04:40Z
dc.date.issued2011-09-21
dc.description.abstractThis publication, which is based on the unique methodology and tools developed for the World Bank Institute/Harvard School of Public Health Flagship Course on Health System Reform and Sustainable Financing, provides a powerful set of resources to help policy makers better navigate the complicated process of reforming pharmaceutical systems. Its problem solving approach complements technical resources and training curricula available on the discrete elements of a pharmaceutical sector. The application of the flagship approach to the pharmaceutical sector is both useful and timely. Ensuring the availability of medicines and the effective management of their procurement and distribution is central to the drive to achieve coverage and access to basic health care that is both universal and financially sustainable. Together, the methodology and case materials contained in this publication provide a rich resource from which policy makers in developing countries may draw to guide their efforts to meet these challenges. This book is designed to help participants gain a better understanding of all that goes on in the pharmaceutical sector. As noted above, it uses the flagship framework that we helped develop over the past decade. The essence of that approach is not to try to tell policy makers in detail what they should do. Rather it comprises a set of analytical tools that are combined into an overall, structured methodology for developing, adopting, and implementing reform proposals. The flagship framework also includes a comprehensive review of reform alternatives and a systematic review of their strengths and weaknesses in various situations. Throughout this book the authors have used the flagship framework to structure our analysis of pharmaceutical reform, continuously and explicitly applying its methods and concepts to the pharmaceutical sector. With a few minor exceptions, all the examples and all of the reform options come directly from pharmaceutical reform efforts around the world. The authors have also given specific attention to issues in pharmaceutical policy related to reproductive health.en
dc.identifierhttp://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000386194_20110928013526
dc.identifier.doi10.1596/978-0-8213-8760-3
dc.identifier.isbn978-0-8213-8760-3
dc.identifier.urihttps://hdl.handle.net/10986/2353
dc.languageEnglish
dc.publisherWorld Bank
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo
dc.subjectABUSE
dc.subjectACCOUNTABILITY
dc.subjectACQUIRED IMMUNODEFICIENCY SYNDROME
dc.subjectBIOLOGICALS
dc.subjectBRAND
dc.subjectBRIBERY
dc.subjectBUDGETING
dc.subjectCANCER
dc.subjectCAPSULES
dc.subjectCARDIOVASCULAR DISEASE
dc.subjectCENTRAL MEDICAL STORES
dc.subjectCHEMISTS
dc.subjectCHILD MORTALITY
dc.subjectCHRONIC DISEASES
dc.subjectCIF
dc.subjectCITIZENS
dc.subjectCITIZENSHIP
dc.subjectCIVIL SOCIETY ORGANIZATIONS
dc.subjectCLINICAL TRIALS
dc.subjectCLINICS
dc.subjectCOMMODITIES
dc.subjectCOMPETITIVE BIDDING
dc.subjectCOMPETITIVENESS
dc.subjectCOMPLICATIONS
dc.subjectCONSUMER GROUPS
dc.subjectCORRUPTION
dc.subjectDEATH RATES
dc.subjectDECISION MAKING
dc.subjectDELIVERY SYSTEMS
dc.subjectDEMOCRACY
dc.subjectDEVELOPING COUNTRIES
dc.subjectDEVELOPMENT GOALS
dc.subjectDEVELOPMENT POLICY
dc.subjectDIABETES
dc.subjectDISABILITY
dc.subjectDISCRIMINATION
dc.subjectDISSEMINATION
dc.subjectDISTRIBUTION SYSTEMS
dc.subjectDOMESTIC MANUFACTURERS
dc.subjectDONOR FINANCING
dc.subjectDOSAGE FORMS
dc.subjectDRUG CONTROL
dc.subjectDRUG DONATIONS
dc.subjectDRUG INDUSTRY
dc.subjectDRUG PRICES
dc.subjectDRUGS
dc.subjectECONOMIC GROWTH
dc.subjectEDUCATION SYSTEMS
dc.subjectEMERGING MARKETS
dc.subjectENVIRONMENTAL PROTECTION
dc.subjectESSENTIAL DRUGS
dc.subjectESSENTIAL MEDICINES
dc.subjectFAMILIES
dc.subjectFAMILY MEMBERS
dc.subjectFAVORITISM
dc.subjectFIXED COSTS
dc.subjectFRAUD
dc.subjectFUTURE GROWTH
dc.subjectGENERIC DRUGS
dc.subjectGLOBAL DEVELOPMENT
dc.subjectGLOBAL POLICY
dc.subjectGMP
dc.subjectGOOD GOVERNANCE
dc.subjectGOOD MANUFACTURING PRACTICES
dc.subjectGOVERNMENT AGENCIES
dc.subjectHEALTH CARE
dc.subjectHEALTH CARE ACCESS
dc.subjectHEALTH CARE PROVIDERS
dc.subjectHEALTH CARE REFORM
dc.subjectHEALTH CARE SYSTEM
dc.subjectHEALTH CENTERS
dc.subjectHEALTH FACILITIES
dc.subjectHEALTH INSURANCE
dc.subjectHEALTH MANAGEMENT
dc.subjectHEALTH OUTCOMES
dc.subjectHEALTH POLICIES
dc.subjectHEALTH POLICY
dc.subjectHEALTH REFORM
dc.subjectHEALTH SECTOR
dc.subjectHEALTH SERVICES
dc.subjectHEALTH SYSTEM
dc.subjectHEALTH SYSTEMS
dc.subjectHEALTH WORKERS
dc.subjectHIGH BLOOD PRESSURE
dc.subjectHIV
dc.subjectHOME COUNTRIES
dc.subjectHOSPITAL
dc.subjectHOSPITALS
dc.subjectHUMAN DEVELOPMENT
dc.subjectHUMAN IMMUNODEFICIENCY VIRUS
dc.subjectILLNESS
dc.subjectILLNESSES
dc.subjectIMMUNIZATION
dc.subjectIMMUNODEFICIENCY
dc.subjectIMPORTED DRUGS
dc.subjectINDUSTRIAL DEVELOPMENT
dc.subjectINDUSTRIAL PRODUCTION
dc.subjectINFORMATION SYSTEMS
dc.subjectINTERMEDIARIES
dc.subjectINTERNATIONAL AGREEMENTS
dc.subjectINTERNATIONAL ORGANIZATIONS
dc.subjectINVENTORY
dc.subjectINVENTORY MANAGEMENT
dc.subjectLABORATORIES
dc.subjectLAWS
dc.subjectLEGAL STATUS
dc.subjectLIFE EXPECTANCY
dc.subjectLOCAL ECONOMY
dc.subjectLOCAL MANUFACTURERS
dc.subjectLOW-INCOME COUNTRIES
dc.subjectLOW-INCOME COUNTRY
dc.subjectMALARIA
dc.subjectMANAGEMENT SYSTEMS
dc.subjectMARKET ENTRY
dc.subjectMARKETING
dc.subjectMEDICAL EDUCATION
dc.subjectMEDICAL NEEDS
dc.subjectMEDICAL SCHOOL
dc.subjectMEDICAL SERVICES
dc.subjectMEDICAL SPECIALISTS
dc.subjectMEDICAL SUPPLIES
dc.subjectMEDICINE
dc.subjectMEDICINES
dc.subjectMILLENNIUM DEVELOPMENT GOALS
dc.subjectMINISTRIES OF HEALTH
dc.subjectMINISTRY OF HEALTH
dc.subjectMORTALITY
dc.subjectNARCOTICS
dc.subjectNATIONAL DRUG
dc.subjectNATIONAL GOVERNMENT
dc.subjectNATIONAL LEGISLATION
dc.subjectNURSE
dc.subjectNURSES
dc.subjectNUTRITION
dc.subjectOPERATING COSTS
dc.subjectPACKAGING
dc.subjectPATIENT
dc.subjectPATIENTS
dc.subjectPAYMENT TERMS
dc.subjectPERSONAL RELATIONSHIPS
dc.subjectPHARMACEUTICAL
dc.subjectPHARMACEUTICAL COMPANIES
dc.subjectPHARMACEUTICAL EXPENDITURE
dc.subjectPHARMACEUTICAL INDUSTRY
dc.subjectPHARMACEUTICAL MANUFACTURERS
dc.subjectPHARMACEUTICAL MARKETING
dc.subjectPHARMACEUTICAL MARKETS
dc.subjectPHARMACEUTICAL POLICIES
dc.subjectPHARMACEUTICAL POLICY
dc.subjectPHARMACEUTICAL PRICING
dc.subjectPHARMACEUTICAL PRICING POLICIES
dc.subjectPHARMACEUTICAL PROCUREMENT
dc.subjectPHARMACEUTICAL PRODUCTS
dc.subjectPHARMACEUTICAL REFORM
dc.subjectPHARMACEUTICAL REGULATION
dc.subjectPHARMACEUTICAL SECTOR
dc.subjectPHARMACEUTICAL SUPPLY
dc.subjectPHARMACEUTICAL ΒΈ MANUFACTURERS
dc.subjectPHARMACEUTICALS
dc.subjectPHARMACIES
dc.subjectPHARMACISTS
dc.subjectPHARMACOLOGISTS
dc.subjectPHARMACY
dc.subjectPHYSICIANS
dc.subjectPOLICY DECISIONS
dc.subjectPOLICY FRAMEWORK
dc.subjectPOLICY GOALS
dc.subjectPOLICY MAKERS
dc.subjectPOLITICAL CHANGE
dc.subjectPOLITICAL DECISION
dc.subjectPOLITICAL OPPOSITION
dc.subjectPOLITICAL SUPPORT
dc.subjectPOOLED PROCUREMENT
dc.subjectPRACTITIONERS
dc.subjectPRESCRIPTIONS
dc.subjectPRICE REGULATION
dc.subjectPRIVATE PHARMACIES
dc.subjectPROCUREMENT
dc.subjectPROGRESS
dc.subjectPUBLIC HEALTH
dc.subjectPUBLIC HEALTH POLICY
dc.subjectPUBLIC POLICY
dc.subjectPUBLIC SUPPORT
dc.subjectPURCHASING
dc.subjectPURCHASING POWER
dc.subjectQUALITY ASSURANCE
dc.subjectQUALITY CONTROL
dc.subjectQUALITY OF CARE
dc.subjectQUANTITATIVE DATA
dc.subjectRATIONAL USE OF DRUGS
dc.subjectREFORM EFFORT
dc.subjectREGULATORY AGENCIES
dc.subjectREGULATORY AUTHORITIES
dc.subjectREGULATORY BARRIERS
dc.subjectRESPECT
dc.subjectRETAIL
dc.subjectRETAIL PHARMACIES
dc.subjectRISK FACTORS
dc.subjectRURAL AREAS
dc.subjectSALES
dc.subjectSECURE SUPPLY
dc.subjectSERVICE DELIVERY
dc.subjectSERVICE PROVIDERS
dc.subjectSERVICE QUALITY
dc.subjectSOCIAL SECURITY
dc.subjectSTOCKS
dc.subjectSUPPLIER
dc.subjectSUPPLIERS
dc.subjectSUPPLY CHAIN
dc.subjectSUPPLY CHAINS
dc.subjectTABLETS
dc.subjectTECHNICAL CAPACITY
dc.subjectTRADE ISSUES
dc.subjectTRANSPORTATION
dc.subjectTUBERCULOSIS
dc.subjectTURNOVER
dc.subjectUNEMPLOYMENT
dc.subjectUNEMPLOYMENT RATES
dc.subjectUNIVERSAL ACCESS
dc.subjectURBAN POPULATION
dc.subjectUSE OF RESOURCES
dc.subjectVACCINES
dc.subjectWAREHOUSE
dc.subjectWAREHOUSES
dc.subjectWHOLESALERS
dc.subjectWORKERS
dc.subjectWORLD HEALTH ORGANIZATION
dc.titlePharmaceutical Reform : A Guide to Improving Performance and Equityen
dspace.entity.typePublication
okr.date.disclosure2011-09-28
okr.doctypePublications & Research::Publication
okr.doctypePublications & Research::Publication
okr.docurlhttp://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000386194_20110928013526
okr.globalpracticeMacroeconomics and Fiscal Management
okr.globalpracticeTransport and ICT
okr.globalpracticeFinance and Markets
okr.globalpracticeTrade and Competitiveness
okr.globalpracticeHealth, Nutrition, and Population
okr.guid767201468168247625
okr.identifier.doi10.1596/978-0-8213-8760-3
okr.identifier.externaldocumentum000386194_20110928013526
okr.identifier.internaldocumentum15156075
okr.identifier.report64666
okr.language.supporteden
okr.pdfurlhttp://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2011/09/28/000386194_20110928013526/Rendered/PDF/646660PUB0Phar00Box361543B00PUBLIC0.pdfen
okr.region.administrativeThe World Region
okr.topicPrivate Sector Development::E-Business
okr.topicHealth, Nutrition and Population::Population Policies
okr.topicHealth, Nutrition and Population::Health Monitoring and Evaluation
okr.topicMacroeconomics and Economic Growth::Markets and Market Access
okr.topicHealth, Nutrition and Population::Pharmaceuticals & Pharmacoeconomics
okr.topicHealth, Nutrition and Population
okr.unitHealth Systems (WBIHS)
okr.volume1 of 1
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
646660PUB0Phar00Box361543B00PUBLIC0.pdf
Size:
3.33 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
646660PUB0Phar00Box361543B00PUBLIC0.txt
Size:
929.32 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Practitioner Handbooks and Guides